header image

Corporate News

Octapharma present new data on the benefits of Nuwiq® in patients with haemophilia A at the World Federation of Hemophilia 2018 World Congress

28.05.2018

Lachen, Switzerland 28 May 2018: Octapharma announced today that new data on the benefits of Nuwiq® in patients with haemophilia A were presented during a symposium at the recent World Federation of Hemophilia (WFH) 2018 World...

Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million

01.03.2018

Lachen, Switzerland, March 1st, 2018: Over the last six years, the Octapharma Group has accomplished a remarkable compound annual growth rate of 15% and reports another record-breaking result for 2017, with sales of €1.72 billion...

Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

22.01.2018

Lachen, Switzerland, January 22nd, 2018: Octapharma is delighted to announce the publication of final data from a Good Clinical Practice (GCP) trial in PUPs in the internationally renowned medical journal Haemophilia. The study...

Schweiz News

Leider gibts es für diesen Archivzeitraum keine übersetzten Artikel.